ABPI appoints Alison Clough as "director of value"

The Association of the British Pharmaceutical Industry has appointed Alison Clough into the newly-created role of director of value. Ms  Clough joins the organization from the UK division of Innovex and will  be responsible for refocusing the National Health Service and National  Institute for Clinical Excellence (NICE), which decides what drugs are  covered in the UK, excluding Scotland, on a value-based approach to  determining which drugs are approved, rather than a cost-based system.